From Wikipedia, the free encyclopedia
Jump to: navigation, search

Serostim (recombinant DNA somatropin) is Serono's brand name prescription drug form of synthetic growth hormone, marketed for AIDS wasting.[1]

In December 2007, the U.S. District Court of Massachusetts settled a class-action lawsuit that involved Merck Serono and the drug Serostim. The lawsuit claims that Merck Serono encouraged doctors to prescribe Serostim off-label for criteria that were not approved by the FDA. Merck Serono denies these claims and any liability. However, Merck Serono has entered into a settlement "solely to avoid the further expense, inconvenience, burden, and uncertainty of these lawsuits."

The settlement will pay consumers of Serostim who paid the full cash amount or a co-payment as part of their medical treatment.


  1. ^

External links[edit]